Artificial sweeteners are often chosen to reduce sugar intake but new laboratory research suggests their effects may extend beyond sweetness. Scientists at the University of Cambridge have found that many commonly used sweeteners can directly influence the growth of gut bacteria, while combinations with medicines and other everyday compounds may change those effects.
The study, published in Molecular Systems Biology in 2026, examined 39 commercially used sweeteners and their interactions with 25 bacterial species. Researchers found that roughly three-quarters of the tested sweeteners affected the growth of at least one bacterial species under laboratory conditions.
One of the most notable findings involved isosteviol, a compound associated with stevia-derived sweeteners, and duloxetine, a medicine prescribed for depression, anxiety and certain types of chronic pain. When tested together, the compounds strongly suppressed two bacterial species associated with gut and metabolic health.
The findings raise questions about how sweeteners behave when consumed alongside other substances. However, the research was conducted in laboratory models, not in people and does not establish that these combinations cause harm in everyday life.
Sweeteners May Do More Than Add Sweetness
Low-calorie sweeteners are widely used in soft drinks, confectionery, desserts, breakfast products and other packaged foods. Some are also included in medicines to improve their taste. They provide sweetness with less or no sugar but their biological effects remain an active area of research.
Scientists have increasingly focused on the gut microbiome the community of bacteria and other microorganisms living in the digestive tract. These microbes help break down food, produce compounds used by the body and interact with immune and metabolic processes.
The composition of the microbiome varies between individuals. Changes in the abundance of particular organisms may be associated with health or disease, although no single microbial profile defines good health for everyone.
Previous studies have investigated possible links between sweeteners and changes in gut bacteria. Yet it can be difficult to determine whether the effects arise from direct interactions with microbes, changes elsewhere in the body or other differences between people’s diets and lifestyles.
The Cambridge researchers set out to investigate a more specific question: can sweeteners directly affect individual gut bacteria and do other compounds change the way those bacteria respond?
Researchers Tested 39 Sweeteners Against 25 Bacterial Species
The team grew 25 bacterial species separately in laboratory cultures. The selection included organisms considered beneficial, relatively neutral or potentially harmful, allowing researchers to compare how different microbes responded to the same substances.
Each bacterial species was exposed to a range of 39 commercially used sweeteners. The scientists then monitored bacterial growth to identify compounds that slowed multiplication or prevented it under the conditions tested.
Approximately 75 per cent of the sweeteners affected at least one species. Some reduced or stopped the growth of bacteria associated with normal digestive and metabolic functions.
These results suggest that certain sweeteners can interact directly with gut microbes rather than simply passing through the digestive system without affecting them.
But laboratory exposure does not automatically reproduce what happens after a person eats or drinks a product. The concentration reaching the gut, the time of exposure and the body’s processing of each compound may all influence the outcome.
Why the Other Ingredients Matter
People rarely consume sweeteners on their own. A diet drink may contain caffeine and flavourings, while a sweetened medicine combines a taste-masking ingredient with an active pharmaceutical compound.
To examine these real-world complexities, the researchers tested sweeteners alongside other substances, including caffeine, vanillin, another sweetener called advantame and eight commonly used medicines.
They identified more than 100 instances in which a sweetener’s effect on bacterial growth changed when another compound was present. In 34 cases, the combined effect became stronger; in 68, it became weaker.
The results indicate that a substance’s effect on bacteria may depend partly on the other compounds surrounding it. A sweetener that has a limited effect when tested alone may behave differently in a mixture, while another combination may reduce an effect seen in isolation.
This does not mean that every sweetened product presents a health risk. Instead, it highlights a limitation of studying food ingredients one at a time: combinations can produce outcomes that are not obvious from individual tests.
The Isosteviol–Duloxetine Combination Stood Out
The strongest result involved isosteviol and duloxetine. Researchers found that the combination substantially suppressed Roseburia intestinalis and Parabacteroides merdae, two bacterial species linked to functions relevant to gut and metabolic health.
The team then moved beyond isolated bacterial cultures by creating a simplified community containing all 25 species. This allowed them to examine how the mixture affected a more complex microbial environment, where different organisms compete and interact.
The isosteviol–duloxetine combination reduced the community’s microbial diversity and changed the relative abundance of different species. Follow-up experiments also indicated changes in effects on certain host-cell models, including processes associated with toxicity, inflammation and immune responses.
These findings provide a reason to investigate interactions between sweeteners, medicines and gut microbes more closely. They do not, however, establish that duloxetine users who consume products containing sweeteners experience the same effects.
The researchers did not demonstrate that the combination causes gut damage in patients, nor did they establish a clinical risk from normal dietary exposure. A simplified microbial community and laboratory cell models cannot reproduce all the processes taking place inside the human body.
What the Study Means for Consumers
The research should not be interpreted as a warning to eliminate all sweeteners. Nor does it show that low-calorie sweeteners are uniformly harmful or that sugar is necessarily a healthier alternative.
Reducing added sugar can remain a useful dietary goal, but the nutritional value of a product depends on its overall ingredients, portion size and place in a person’s diet. The findings also do not prove that sweeteners cause conditions such as obesity, diabetes or cancer. Associations reported in other research require separate evaluation and cannot be established by this experiment alone.
Most importantly, people taking duloxetine or other prescribed medicines should not stop treatment or change their dose because of these laboratory results. Medication decisions should be discussed with a qualified healthcare professional.
The study instead points towards a more detailed understanding of how food ingredients and medicines interact with the microbiome. Future research will need to determine whether the effects occur in people, whether they happen at concentrations associated with ordinary consumption and whether they lead to measurable changes in health.
The Next Step Is Research in Humans
The Cambridge findings offer a closer look at how common compounds can influence the growth of gut bacteria under controlled conditions. By testing mixtures as well as individual ingredients, the researchers have identified interactions that may otherwise be overlooked.
But laboratory evidence is an early step, not a final health verdict. The human gut contains a complex, changing ecosystem shaped by diet, medication, age, genetics and many other factors. The effects observed in a test tube may not occur in the same way in an actual digestive system.
Human studies will be essential to establish whether these interactions matter at everyday exposure levels and whether any changes have meaningful consequences for health.
For now, the central lesson is not that sweeteners should be feared but that their biological effects may be more complicated than previously assumed. Understanding those effects will require research that moves beyond individual ingredients and examines how the substances people consume work together.
Jaweria Nazeer
About Author:
The author is a writer who focuses on social issues and nutrition. Their work highlights topics such as inequality, education, human rights and healthy lifestyle habits aiming to inform readers and promote positive awareness and change.
Keywords: artificial sweeteners, gut bacteria, gut microbiome, isosteviol, duloxetine, University of Cambridge, low-calorie sweeteners, nutrition research
Asian Burg / Health & Nutrition
